Page last updated: 2024-12-05

cinnoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cinnoline is a heterocyclic aromatic compound with the formula C8H6N2. It is a colorless liquid that is soluble in organic solvents. Cinnoline is a nitrogen analog of quinoline, and it is a member of the diazine class of compounds. Cinnoline can be synthesized by the reaction of o-phenylenediamine with glyoxal. Cinnoline is a versatile building block for the synthesis of many other heterocyclic compounds. It is also a potential target for drug development, as it has been shown to have a variety of biological activities, including anti-inflammatory, antibacterial, and anticancer effects. Cinnoline has been studied for its use in the synthesis of pharmaceutical compounds, as well as for its potential in materials science and agriculture. Its structure and electronic properties allow for its use in the synthesis of various pharmaceuticals, such as anti-cancer drugs, anti-inflammatory agents, and antibiotics. Cinnoline derivatives are also studied for their potential applications in materials science, such as in the development of organic electronics, as well as in agriculture for their potential herbicidal and insecticidal properties. '

cinnoline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cinnoline : An azaarene that is the 1,2-diaza analogue of naphthalene. The parent of the class of cinnolines. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9208
CHEMBL ID479792
CHEBI ID36617
SCHEMBL ID8197
SCHEMBL ID18935280
MeSH IDM0452603

Synonyms (28)

Synonym
alpha-phenodiazine
benzopyridazine
CHEBI:36617 ,
benzo[c]pyridazine
1,2-diazanaphthalene
1,2-benzodiazine
.alpha.-phenodiazine
nsc58374
nsc-58374
253-66-7
inchi=1/c8h6n2/c1-2-4-8-7(3-1)5-6-9-10-8/h1-6
cinnoline
CHEMBL479792
unii-n5kd6i506o
nsc 58374
einecs 205-964-8
n5kd6i506o ,
AKOS006228456
FT-0631891
SCHEMBL8197
cinnoline [mi]
DTXSID60179943
SCHEMBL18935280
mfcd00006812
Q413130
AS-40502
A877609
CS-0155964

Research Excerpts

Overview

Cinnoline is a potential pharmacophore which has rarely been reported for uses as PI3K inhibitors. Cinnoline nucleus is a very important bicyclic heterocycle that is used as the structural subunit of many compounds with interesting pharmaceutical properties.

ExcerptReferenceRelevance
"Cinnoline is a potential pharmacophore which has rarely been reported for uses as PI3K inhibitors. "( Discovery of cinnoline derivatives as potent PI3K inhibitors with antiproliferative activity.
Chen, Y; Deng, M; Jia, Y; Ling, Y; Liu, X; Lu, M; Tian, C; Wu, T; Yang, C; Yang, Y; Zhou, Y, 2021
)
2.43
"The cinnoline nucleus is a very important bicyclic heterocycle that is used as the structural subunit of many compounds with interesting pharmaceutical properties. "( Cinnoline Scaffold-A Molecular Heart of Medicinal Chemistry?
Stanczak, A; Szumilak, M, 2019
)
2.51

Toxicity

ExcerptReferenceRelevance
" IC50 data for the NALM-6 cell line are lower than for the HL-60 cell line, what suggested that the HL-60 leukemia cells are more resistant to toxic action of tested compounds."( Synthesis and cytotoxicity of new potential intercalators based on tricyclic systems of some pyrimido[5,4-c]cinnoline and pyrimido[5,4-c]quinoline derivatives. Part I.
Krajewska, U; Lewgowd, W; Ochocki, Z; Rózalski, M; Stańczak, A,
)
0.34

Bioavailability

ExcerptReferenceRelevance
" The 5-isoquinoline-containing compound 14a (hTRPV1 IC50 = 4 nM) exhibited 46% oral bioavailability and in vivo activity in animal models of visceral and inflammatory pain."( Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.
Bayburt, EK; Didomenico, S; Drizin, I; Faltynek, CR; Gomtsyan, A; Hannick, SM; Honore, P; Jarvis, MF; Jinkerson, T; Koenig, JR; Lee, CH; Macri, BS; Marsh, KC; McDonald, HA; Oie, T; Perner, RJ; Schmidt, RG; Stewart, KD; Surowy, CS; Turner, S; Wetter, J; Wismer, CT; Zheng, GZ, 2005
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
mancude organic heterobicyclic parent
cinnolinesAny organic heteropolycyclic compound based on the 1,2-diaza analogue of naphthalene and its substituted derivatives.
azaarene
ortho-fused heteroareneAn ortho-fused compound in which at least one of the rings contains at least one heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID343684Alkane-water partition coefficient, log P of the compound2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID343683Octanol-water partition coefficient, log P of the compound2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (95)

TimeframeStudies, This Drug (%)All Drugs %
pre-199031 (32.63)18.7374
1990's0 (0.00)18.2507
2000's16 (16.84)29.6817
2010's36 (37.89)24.3611
2020's12 (12.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.11 (24.57)
Research Supply Index4.60 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index91.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (57.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (6.12%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other92 (93.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]